Cover Image

Ambrisentan for the treatment of pulmonary arterial hypertension

Brian Casserly1,3, James R Klinger2,31Division of Pulmonary Medicine, The Memorial Hospital of Rhode Island, Pawtucket, RI, USA; 2Division of Pulmonary Sleep and Critical Care Medicine, Rhode Island Hospital; 3Waren Alpert Medical School of Brown University, Providence, RI, USAAbstract: Ambrisentan...

Full description

Saved in:

Bibliographic Details
Main Authors:	Brian Casserly (Author), James R Klinger (Author)
Format:	Book
Published:	Dove Medical Press, 2008-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent
by: Brian Casserly, et al.
Published: (2009)

The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study
by: Yusi Chen, et al.
Published: (2022)

A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients
by: Dunbar Ivy, MD, et al.
Published: (2020)

Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
by: Yusi Chen, et al.
Published: (2022)

Extractive Spectrophotometric Determination of Ambrisentan
by: Chandra Bala Sekaran, et al.
Published: (2013)

Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension
by: Xinmei Li, et al.
Published: (2020)

Bladder Endothelin-1 Receptor Binding of Bosentan and Ambrisentan
by: Ayaka Osano, et al.
Published: (2014)

Evaluation of herb-drug interaction of ambrisentan with shikonin based on UPLC-MS/MS
by: Tian Lan, et al.
Published: (2021)

Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension
by: Zolty R
Published: (2021)

Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH
by: Miren Bravo, et al.
Published: (2021)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension
by: Naoyuki Otani, et al.
Published: (2022)

Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children
by: Benjamin S. Frank, et al.
Published: (2018)

Echocardiographic Assessment of Pulmonary Arterial Hypertension for Pediatricians and Neonatologists
by: Gregory James Skinner
Published: (2017)

Manejo farmacológico da hipertensão arterial pulmonar Treatment of pulmonary arterial hypertension
by: Cláudia Pires Ricachinevsky, et al.
Published: (2006)

Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia
by: Oktavia Lilyasari, et al.
Published: (2019)

Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
by: Hardin EA, et al.
Published: (2016)

Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension
by: Allan K. N. Alencar, et al.
Published: (2017)

Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
by: Gautam V Ramani, et al.
Published: (2010)

Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Alexis Coulis, et al.
Published: (2024)

Genetics and Genomics of Pulmonary Arterial Hypertension
Published: (2022)

Proteomic analysis of pulmonary arterial hypertension
by: Xiaohan Qin, et al.
Published: (2021)

Drug-induced pulmonary artery hypertension
by: O. D. Ostroumova, et al.
Published: (2022)

Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting
by: Heather Torbic PharmD, FCCM, BCPS, BCCCP, et al.
Published: (2024)

Targeting IL-11 system as a treatment of pulmonary arterial hypertension
by: Javier Milara, et al.
Published: (2023)

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension
by: Wenxing Dong, et al.
Published: (2023)

Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
by: Zhifeng Xue, et al.
Published: (2021)

Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension
by: Monaco TJ, et al.
Published: (2016)

Evaluation of Nicorandil in Treatment of induced pulmonary arterial hypertension in male Rats
by: Taha Hashim Ahmed, et al.
Published: (2024)

Bosentan for Treatment of Pediatric Idiopathic Pulmonary Arterial Hypertension: State-of-the-Art
by: Yuchen Wang, et al.
Published: (2019)

Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
by: Bodil Ivarsson, et al.
Published: (2014)

Pulmonary arteriovenous malformations with pulmonary artery hypertension: Therapeutic implication
by: Jayachandra, et al.
Published: (2020)

Safety and tolerability of bosentan in the management of pulmonary arterial hypertension
by: Kari E Roberts, et al.
Published: (2009)

Role of Gender in Regulation of Redox Homeostasis in Pulmonary Arterial Hypertension
by: Ruslan Rafikov, et al.
Published: (2019)

Principles of pharmacological correction of pulmonary arterial hypertension
by: Mikhail Korokin, et al.
Published: (2018)

Novel and emerging therapies in pulmonary arterial hypertension
by: Steven J. Cassady, et al.
Published: (2022)

Prostanoid therapies in the management of pulmonary arterial hypertension
by: LeVarge BL
Published: (2015)

Quality of life in patients with pulmonary arterial hypertension
by: Mirosława Anna Kowalkowska, et al.
Published: (2023)

The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension
by: Faye E. Smits, et al.
Published: (2024)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
by: Jina Yeo, et al.
Published: (2022)

Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
by: Ran-ran Wang, et al.
Published: (2022)